Further research directions could include evaluating the level of adipolin in patients with GDM later in life as a predictor of T2DM occurrence as there is evidence that the adipolin level is lower in patients with T2DM [29], and it is known that one of the long-term complications of GDM is T2DM [10,11]. This evidence concerns the gene C1QTNF12 and gestational diabetes.